Recombinant Human NRG1/HRG1-alpha EGF domain Fc Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 11343-NR
Fc Chimera
Key Product Details
Source
HEK293
Accession #
Structure / Form
Disulfide-linked homodimer
Conjugate
Unconjugated
Applications
Bioactivity
Product Specifications
Source
Human embryonic kidney cell, HEK293-derived human Neuregulin-1/NRG1 protein
Human NRG1/HRG1-alpha EGF domain (Ser177-Pro226) Accession # NP_039254.1 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
N-terminus | C-terminus |
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Ser177
Predicted Molecular Mass
32 kDa
SDS-PAGE
36-43 kDa, under reducing conditions.
Activity
Measured in a serum-free cell proliferation assay using MCF-7 human breast cancer cells. Karey, K.P. et al. (1988) Cancer Research 48:4083.
The ED50 for this effect is 4.00‑40.0 ng/mL.
The ED50 for this effect is 4.00‑40.0 ng/mL.
Scientific Data Images for Recombinant Human NRG1/HRG1-alpha EGF domain Fc Protein, CF
Recombinant Human NRG1/HRG1-alpha EGF domain Fc Chimera Protein Bioactivity.
Recombinant Human NRG1/HRG1-alpha EGF domain Fc Chimera Protein (Catalog # 11343-NR) stimulates proliferation of MCF 7 human breast cancer cells. The ED50 for this effect is 4.00-40.0 ng/mL.Recombinant Human NRG1/HRG1-alpha EGF domain Fc Chimera Protein SDS-PAGE.
2 μg/lane of Recombinant Human NRG1/HRG1-alpha EGF domain Fc Chimera Protein (Catalog # 11343-NR) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 36-43 kDa and 72-86 kDa, respectively.Formulation, Preparation and Storage
11343-NR
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
Reconstitution | Reconstitute at 500 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Neuregulin-1/NRG1
References
- Mei, L. and W.-C. Xiong (2008) Nat. Rev. Neurosci. 9:437.
- Talmage, D.A. (2008) Novartis Found. Symp. 289:74.
- Holmes, W.E. et al. (1992) Science 256:1205.
- Marchionni, M.A. et al. (1993) Nature 362:312.
- Ho, W.-H. et al. (1995) J. Biol. Chem. 270:14523.
- Wen, D. et al. (1994) Mol. Cell. Biol. 14:1909.
- Meyer, D. et al. (1997) Development 124:3575.
- Hu, X. et al. (2006) Nat. Neurosci. 9:1520.
- Willem, M. et al. (2006) Science 314:664.
- Yokozeki, T. et al. (2007) Genes Cells 12:329.
- Bao, J. et al. (2003) J. Cell Biol. 161:1133.
- Lemmens, K. et al. (2007) Circulation 116:954.
- Breleux, M. (2007) Cell. Mol. Life Sci. 64:2358.
- Zhang, P. et al. (2018) JCI Insight. 3:e98522.
Alternate Names
Heregulin-1, HGL, HRG1-alpha, HRG1-beta 1, Neuregulin1, NRG1
Gene Symbol
NRG1
UniProt
Additional Neuregulin-1/NRG1 Products
Product Documents for Recombinant Human NRG1/HRG1-alpha EGF domain Fc Protein, CF
Product Specific Notices for Recombinant Human NRG1/HRG1-alpha EGF domain Fc Protein, CF
For research use only
Loading...
Loading...
Loading...